20th Aug 2025 09:03
(Sharecast News) - Convatec surged on Wednesday as the medical products company launched a share buyback programme of up to $300m.
The programme will run up to the end of December and may be extended by further notification, Convatec said.
UBS will conduct the buyback programme.
At 0900 BST, the shares were up 7.3% at 248.04p.
Danni Hewson, head of financial analysis at AJ Bell, said the buyback "proved a comforting balm for investors".